Weights of each ecosystem service category during the study period. by Bao Zhou (20670850)

Subjects:

Spatio-temporal changes in SDG under multi-scenario spatio-temporal scenarios. by Bao Zhou (20670850)

Subjects:

Weighting settings for land use projections across multiple scenarios. by Bao Zhou (20670850)

Subjects:

Study area. by Bao Zhou (20670850)

Subjects:

LUC in southeast Yunnan under different scenarios in 2035. by Bao Zhou (20670850)

Subjects:

Distribution of ESs and hot and cold spots during the historical period. by Bao Zhou (20670850)

Subjects:

Spatial distribution of ESs. by Bao Zhou (20670850)

Subjects:

Correspondence of support for SDGs across ESs categories. by Bao Zhou (20670850)

Subjects:

The result of molecular dynamics simulation. by Ashraf Attia Mahmoud (21262201)

“…The docking research indicated that these mutations decreased the binding affinity for DNA, with R273C, R280G, G266E, and G105C displaying the most significant differences. …”

Result of the phenotypic analysis. by Ashraf Attia Mahmoud (21262201)

“…The docking research indicated that these mutations decreased the binding affinity for DNA, with R273C, R280G, G266E, and G105C displaying the most significant differences. …”

Type of Mutations. by Ashraf Attia Mahmoud (21262201)

“…The docking research indicated that these mutations decreased the binding affinity for DNA, with R273C, R280G, G266E, and G105C displaying the most significant differences. …”

Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality. by Jennifer M. Kwan (3350321)

Subjects:

Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

Subjects:

Adverse cardiovascular events by immune checkpoint inhibitor. by Jennifer M. Kwan (3350321)

Subjects:

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

Subjects:

Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer deaths by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Hospitalizations for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized hospitalization rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Mortality for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects: